Further to its letters dated 18.05.2022 & 30.05.2022, Vivimed Labs has informed that the Board of Directors of the Company at its meeting held on Friday, 3rd June, 2022 has approved the Audited Financial Results for the quarter and year ended 31 March, 2022. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the company enclosed the following: Statement of Audited Standalone Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon, Statement of Audited Consolidated Financial Results for the quarter and year ended 31 March, 2022 and Auditors' Report thereon and Declaration regarding Audit Reports with unmodified opinion.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: